Scout-HCM News

Latest Articles

• Phase 3 Trial Demonstrates First-in-Class Drug Successfully Reduces Heart Obstruction in Adolescent Patients

  Published: Mar 30, 2026

  Section: Research

  The Scout-HCM trial presented at ACC.26 marks the first successful testing of mavacamten in patients under the age of 18 with obstructive hypertrophic cardiomyopathy. Results indic...